1315 Capital Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, 1315 Capital has acquired 2 companies. It has also invested in 1 other.

1315 Capital’s most common sectors for investment are medical products (45%) and life science (34%). The Firm’s most common investment types include venture (45%) and buyout (lbo, mbo, mbi) (23%). In total, 1315 Capital has invested in 6 US states.

In the last 3 years, 1315 Capital has exited 1 company. The Firm’s most common exit type is trade sale (100%). 1315 Capital’s largest (disclosed) exit occurred in 2018 when it sold Genoptix for $126M.

Join Mergr to view 1315 Capital’s full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity10
    • M&A Buy Activity9
    • M&A Sell Activity1
  • Total Sectors Invested 4
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 4

1315 Capital

2929 Walnut Street, Suite 1240,
Philadelphia, Pennsylvania 19104
United States
(215) 662-1315
www.1315capital.com

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $30 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 5 100
Target EBITDA - -
Investment Size 10 30
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.8/yr) # 5 1 - 1 2 - 9
Sell (0.2/yr) # - - 1 - - - 1
vol $126M $126M
  10

Most Recent M&A

Company Date Value Type
Centurion Service Group 2020-02-10 - Buyout (LBO, MBO, MBI)
Franklin Park, Illinois · www.centurionservice.com
Interpace Biosciences, Inc. 2020-01-13 - Stake Purchase
Parsippany, New Jersey · www.interpace.com
Biocoat, Inc. 2019-01-16 - Buyout (LBO, MBO, MBI)
Horsham, Pennsylvania · www.biocoat.com
Genoptix, Inc. 2018-10-23 126M USD Add-on Acquisition
Carlsbad, California · www.genoptix.com
Genoptix, Inc. 2017-03-07 - Divestiture
Carlsbad, California · www.genoptix.com
Encore Dermatology, Inc. 2016-06-15 - Venture
Malvern, Pennsylvania · www.encorederm.com
JDS Therapeutics LLC 2015-10-22 - Venture
Purchase, New York · www.jdstherapeutics.com
Onkos Surgical, Inc. 2015-10-06 - Venture
Parsippany, New Jersey · www.onkossurgical.com
Interphase Medical Equipment 2015-01-01 - Growth Capital
Philadelphia, Pennsylvania · www.interphasemedical.com
Innovative Health LLC 2014-01-01 - Venture
Scottsdale, Arizona · www.innovative-health.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 4 (50%) - 4 (44%) -
Life Science 3 (38%) - 3 (33%) -
Chemicals 1 (13%) - 1 (11%) -
Healthcare Services - - 1 (11%) -
Total 8 - 9 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 8 (100%) - 9 (100%) -
  Pennsylvania 3 (38%) - 3 (33%) -
  New Jersey 2 (25%) - 2 (22%) -
  New York 1 (13%) - 1 (11%) -
  Illinois 1 (13%) - 1 (11%) -
  Arizona 1 (13%) - 1 (11%) -
  California - - 1 (11%) -
Total 8 - 9 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 4 (50%) - 4 (44%) -
Buyout (LBO, MBO, MBI) 2 (25%) - 2 (22%) -
Divestiture - - 1 (11%) -
Growth Capital 1 (13%) - 1 (11%) -
Stake Purchase 1 (13%) - 1 (11%) -
Total 8 - 9 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 1 (100%) 126M (100%)
Total 1 $126M

Deal Values

sell # Total
$100M to $1B 1 $126M
TOTAL $126M
Largest Genoptix, Inc.
$126M (2018-10-23)

M&A Connections

Deals
Acquired from
Strategic(s)
11%
1 (11%)
Exited to
Strategic(s)
100%
1 (100%)

Investor Summary

Size

Small

Established

2014

Specialist/Generalist

Specialist

Leadership

Adele Oliva

Founding Partner

Michael Koby

Founding Partner

Brian Schwenk

CFO & CCO

Matthew Reber

Partner

Antony Koblish

Operating Partner

 Subscribe to unlock this and 161,149
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 150K M&A Transactions
  • 157K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 48K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal